Vidrala, S.A. Q3 2026 Earnings Recap

Vidrala’s shares fell 5.0% after results, with investors likely focused on a 3% organic sales decline and management’s description of European demand as weaker than expected. The company reiterated full-year guidance, but revenue pressure and the tough industry backdrop temper the positives from resilient margins and cash generation.

Key Takeaways

• Nine-month reported revenue was €1,146.5 million; organic sales declined 3% year on year, including an anticipated 1.2% price adjustment.
• Nine-month EBITDA was €338.5 million, down 0.5% organically; the EBITDA margin rose 27 basis points to 29.5%.
• Management cited weak demand in mature European markets and stronger performance in South America, while noting persistent inflationary pressures and intense competition.
• Net debt was €201 million at September-end, or 0.4x last-twelve-month pro forma EBITDA. Nine-month free cash flow was in line with expectations, and the company remained on track for around €200 million for the full year.
• Vidrala reiterated 2026 guidance: EBITDA of around €450 million, EPS growth above 5%, and underlying free cash flow of around €200 million, excluding restructuring costs.